We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

80 hedge funds and large institutions have $80.4M invested in abrdn Life Sciences Investors in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 24

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

8% more capital invested

Capital invested by funds: $74.4M → $80.4M (+$5.95M)

3.62% more ownership

Funds ownership: 20.97% → 24.59% (+3.6%)

3% more funds holding

Funds holding: 78 → 80 (+2)

Holders
80
Holders Change
+2
Holders Change %
+2.56%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
34
Reduced
24
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LSC
Logan Stone Capital
Illinois
+$2.23M
2
RL
RPO LLC
Connecticut
+$1.85M
3
SCM
Saba Capital Management
New York
+$1.77M
4
CCP
Clough Capital Partners
Massachusetts
+$1.72M
5
AA
AQR Arbitrage
Connecticut
+$1.7M

Top Sellers

Rank Fund Capital Flow
1
RJA
Raymond James & Associates
Florida
-$1.8M
2
Wells Fargo
Wells Fargo
California
-$1.26M
3
WP
Woodline Partners
California
-$716K
4
Cohen & Steers
Cohen & Steers
New York
-$395K
5
JP Morgan Chase
JP Morgan Chase
New York
-$272K
Name Holding Trade Value Shares
Change 		Change in
Stake
QL
26
Quarry LP
New York
$776K +$819K +62,250 New
Walleye Capital
27
Walleye Capital
New York
$623K -$42.8K -3,257 -6%
Stifel Financial
28
Stifel Financial
Missouri
$621K -$54.1K -4,110 -8%
Cohen & Steers
29
Cohen & Steers
New York
$590K -$395K -30,000 -39%
LCM
30
Landscape Capital Management
New Jersey
$587K +$262K +19,921 +73%
RJFSA
31
Raymond James Financial Services Advisors
Florida
$577K -$203K -15,439 -25%
UBS Group
32
UBS Group
Switzerland
$547K -$56.1K -4,268 -9%
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$507K +$101K +7,717 +23%
Commonwealth Equity Services
34
Commonwealth Equity Services
Massachusetts
$485K -$83.1K -6,315 -14%
Qube Research & Technologies (QRT)
35
Qube Research & Technologies (QRT)
United Kingdom
$467K – – –
KWM
36
Kingsview Wealth Management
Oregon
$449K -$8.6K -654 -2%
AUB
37
Atlantic Union Bankshares
Virginia
$439K -$57.3K -4,357 -11%
PAG
38
Private Advisor Group
New Jersey
$435K +$203K +15,459 +79%
AWS
39
Atria Wealth Solutions
New York
$406K -$5.89K -448 -1%
HighTower Advisors
40
HighTower Advisors
Illinois
$394K +$421K +31,991 New
Millennium Management
41
Millennium Management
New York
$364K +$242K +18,398 +170%
GC
42
Guggenheim Capital
Illinois
$351K +$1.47K +112 +0.4%
RJA
43
Raymond James & Associates
Florida
$346K -$1.8M -136,694 -83%
NA
44
NewEdge Advisors
Louisiana
$323K -$65.7K -4,994 -16%
AW
45
Atlas Wealth
Ohio
$311K +$156K +11,879 +91%
WS
46
Wedbush Securities
California
$284K +$39.5K +3,000 +15%
EC
47
Elequin Capital
New York
$283K +$298K +22,675 New
KAS
48
KPP Advisory Services
Kentucky
$275K +$290K +22,028 New
Wealth Enhancement Advisory Services
49
Wealth Enhancement Advisory Services
Minnesota
$260K +$275K +20,880 New
OC
50
Oppenheimer & Co
New York
$219K +$5.12K +389 +2%
1
2
3 4

HQL Hedge Fund Activity: Q3 2023 in Review

80 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2023, worth a combined $80.4M — up 8% from $74.4M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new HQL positions and 8 closed out — a net gain of 3 holders — while 34 added to existing stakes and 24 trimmed.

The largest buyer was Logan Stone Capital, adding an estimated $2.23M. The largest seller was Raymond James & Associates, cutting an estimated $1.8M.

  • 80 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2023, up from 78 in Q2 2023.
  • Funds reported $80.4M of abrdn Life Sciences Investors stock for Q3 2023, up 8% quarter-over-quarter.
  • 11 funds opened new abrdn Life Sciences Investors positions in Q3 2023 and 8 closed out, a net change of +3 holders.
  • The largest abrdn Life Sciences Investors buyer in Q3 2023 was Logan Stone Capital, an estimated $2.23M added.
  • The largest abrdn Life Sciences Investors seller in Q3 2023 was Raymond James & Associates, an estimated $1.8M sold.

Based on aggregated 13F filings for Q3 2023.